Literature DB >> 18927453

Comparison of methods for magnetic resonance-guided [18-F]fluorodeoxyglucose positron emission tomography in human carotid arteries: reproducibility, partial volume correction, and correlation between methods.

David Izquierdo-Garcia1, John R Davies, Martin J Graves, James H F Rudd, Jonathan H Gillard, Peter L Weissberg, Tim D Fryer, Elizabeth A Warburton.   

Abstract

BACKGROUND AND
PURPOSE: Inflammation is a major risk factor for atherosclerotic plaque rupture and clinical events. Previous studies have shown that plaque [(18)F]fluorodeoxyglucose (FDG) uptake correlates with macrophage content. In this study we examined the reproducibility of 3 methods of quantifying plaque FDG uptake in the carotid arteries using positron emission tomography (PET). The correlation between 2 simplified uptake parameters (standardized uptake value [SUV], vessel wall-to-blood ratio [VBR]) and a gold standard technique (influx rate [K(i)]) was also determined. We used MRI to correct carotid plaque FDG uptake for partial volume error.
METHODS: Seven patients with a recent carotid territory transient ischemic attack underwent imaging twice within 8 days using MR and FDG-PET. MR coregistered to PET was used to delineate regions of interest, and to facilitate partial volume correction (PVC).
RESULTS: SUV was the most reproducible parameter irrespective of whether it was normalized by body surface area (BSA), lean body mass, or weight (intraclass correlation coefficient=0.85, 0.88, and 0.90, respectively). VBR correlated better to K(i) than SUV (r=0.58 VBR, r=0.46 SUV(BSA)). PVC improved these correlations to r=0.81 VBR and r=0.76 SUV(BSA), and only slightly degraded the reproducibility of SUV (intraclass correlation coefficient=0.83-0.85).
CONCLUSIONS: MR-guided FDG-PET is a highly reproducible technique in the carotid artery and the excellent anatomic detail provided by MR facilitates PVC. Of the methods examined, SUV(BSA)(PVC) appears to represent the best compromise between reproducible and accurate determination of FDG metabolism in carotid artery vessel wall.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927453     DOI: 10.1161/STROKEAHA.108.521393

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

1.  Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice.

Authors:  M Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03       Impact factor: 9.236

2.  PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model.

Authors:  Xingyu Nie; Richard Laforest; Andrew Elvington; Gwendalyn J Randolph; Jie Zheng; Tom Voller; Dana R Abendschein; Suzanne E Lapi; Pamela K Woodard
Journal:  J Nucl Med       Date:  2016-07-07       Impact factor: 10.057

Review 3.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

4.  Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET/MR imaging.

Authors:  David Izquierdo-Garcia; Stephen J Sawiak; Karin Knesaurek; Jagat Narula; Valentin Fuster; Joseph Machac; Zahi A Fayad
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-21       Impact factor: 9.236

5.  Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study.

Authors:  Cecilia Marini; Silvia Morbelli; Riccardo Armonino; Giovanni Spinella; Mattia Riondato; Michela Massollo; Francesca Sarocchi; Bianca Pane; Carla Augeri; Luca Abete; Giorgio Ghigliotti; Daniela Palmieri; Francesco Fiz; Giuseppe Cittadini; Ezio Fulcheri; Domenico Palombo; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-20       Impact factor: 9.236

6.  Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation.

Authors:  Amr Abdelbaky; Ahmed Tawakol
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

7.  Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in (18)F-FDG PET/MR emission data and comparison to PET/CT.

Authors:  Jason Bini; Philip M Robson; Claudia Calcagno; Mootaz Eldib; Zahi A Fayad
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

8.  Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction.

Authors:  Björn A Blomberg; Arjun Bashyam; Abhinay Ramachandran; Saeid Gholami; Sina Houshmand; Ali Salavati; Tom Werner; Habib Zaidi; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-12       Impact factor: 9.236

9.  Optimizing FDG-PET/CT imaging of inflammation in atherosclerosis.

Authors:  Antti Saraste; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2015-03-31       Impact factor: 5.952

10.  Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.

Authors:  A Millon; S D Dickson; A Klink; D Izquierdo-Garcia; J Bini; E Lancelot; S Ballet; P Robert; J Mateo de Castro; C Corot; Z A Fayad
Journal:  Atherosclerosis       Date:  2013-03-26       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.